Medicare Part D Proposed Rule To Lower Prices Targets PBMs, Benefits Manufacturers

The Centers for Medicare and Medicaid Services is proposing to lower drug prices for beneficiaries in the Medicare Part D program without tapping manufacturer revenues and in fact, could end up boosting them.

Effective beginning in 2023, CMS would require Part D plans and pharmacy benefit managers to pass through pharmacy price concessions at the point of sale under a proposed rule released 6 January